WWD:NASDAQWoodward, Inc. Analysis
Data as of 2026-08-02 - not real-time
$360.75
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Woodward, Inc. posted a 21% year‑over‑year revenue surge and a 43% jump in adjusted EPS, beating analyst expectations and earning a Zacks Rank 1 Strong Buy. Revenue growth and expanding margins underpin a compelling growth narrative, further reinforced by its recent migration into growth‑focused Russell indices and recognition on TIME’s America’s Best Companies list. However, the stock trades at a price‑to‑earnings multiple near 40, well above the aerospace & defense industry average, and the discounted cash‑flow model suggests a fair value around $80, indicating a substantial overvaluation premium. Technical indicators show a bearish MACD histogram and an RSI in the low‑30s, suggesting short‑term momentum weakness despite a broader bullish trend direction. The recent 9% intra‑day decline after earnings reflects market skepticism about the lofty price level. With a beta above 1 and 30‑day volatility approaching 38%, price swings are pronounced, yet the company’s low payout ratio and solid free cash flow support dividend sustainability. The combination of strong fundamentals, growth‑oriented market perception, and elevated valuation creates a nuanced risk‑reward profile that favors medium‑ to long‑term positioning while cautioning against near‑term entry.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD divergence and low RSI signaling downside pressure
- Current price significantly above DCF fair value
- Recent 9% price drop reflecting market re‑pricing
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust 21% revenue growth and margin expansion
- Strong earnings beat and upgrade to Strong Buy
- Inclusion in growth‑focused indices supporting demand outlook
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained aerospace and industrial demand fundamentals
- Low dividend payout ratio ensuring cash‑flow flexibility
- Recognition for ESG performance and employee satisfaction bolstering brand resilience
Key Metrics & Analysis
Financial Health
Revenue Growth21.20%
Profit Margin13.17%
P/E Ratio40.2
ROE22.34%
ROA8.62%
Debt/Equity55.94
P/B Ratio8.5
Op. Cash Flow$585.3M
Free Cash Flow$187.2M
Industry P/E30.9
Technical Analysis
TrendBullish
RSI33.9
Support$343.65
Resistance$428.59
MA 20$399.38
MA 50$392.91
MA 200$348.17
MACDBearish
VolumeIncreasing
Fear & Greed Index92.88
Valuation
Fair Value$80.80
Target Price$449.00
Upside/Downside24.46%
GradeOvervalued
TypeGrowth
Dividend Yield0.35%
Risk Assessment
Beta1.17
Volatility37.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.